MYOD1 and neoplasm: On immunohistochemical analysis the tumor cells were strongly positive for MyoD1 (Fig. 6), myogenin (Fig. 7), and the neuroendocrine cell marker PGP9.5, and weakly positive for desmin, actin, vimentin, CD56, and Syn.